![Susan Wyrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Wyrick
Comptroller/Controller/Auditor bei
SANA BIOTECHNOLOGY, INC.
Vermögen: 684 724 $ am 30.06.2026
Profil
Ms. Susan D.
Wyrick, CPA, is a Senior Vice President-Finance & Accounting at Sana Biotechnology, Inc. Ms. Wyrick was previously employed as a Vice President & Controller by Juno Therapeutics, Inc. and a Chief Accounting Officer & Vice President-Finance by OncoGenex Pharmaceuticals, Inc. She received her undergraduate degree from the University of Washington.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC. 0,08 % | 09.03.2026 | 196.196 ( 0,08 % ) | 684 724 $ | 30.06.2026 |
Aktive Positionen von Susan Wyrick
| Unternehmen | Position | Beginn |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 04.10.2024 |
Ehemalige bekannte Positionen von Susan Wyrick
| Unternehmen | Position | Ende |
|---|---|---|
| JUNO THERAPEUTICS INC | Comptroller/Controller/Auditor | 01.10.2018 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Comptroller/Controller/Auditor | 11.06.2014 |
Ausbildung von Susan Wyrick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
